BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 3, 2007
View Archived Issues
Array Raises $91M Publicly For Cancer, Inflammation Programs
Array BioPharma Inc. raised $91 million in a public offering of stock, money that will be used to fund development of its broad, early stage pipeline of small-molecule drug candidates for cancer and inflammatory diseases. (BioWorld Today)
Read More
Varying FOB Proposals Seem To Signal Compromise In The Works
Read More
Specific Starvation Gene Joins Sirtuins As Longevity Target
Read More
NeurogesX Lowers Share Price Again, Brings In $44M In IPO
Read More
AVI, Ercole Join Technologies To Tackle DMD, Thalassemia
Read More
Immunomedics Raises $24M For Anticancer Antibodies
Read More
Other News To Note
Read More
Clinic Roundup
Read More